HighTower Advisors »

Revolution Medicines shares owned by HighTower Advisors

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $393k 10k 38.92
2023-09-30 $297k 11k 27.61

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl A (GOOGL)
Sharkninja Com Shs (SN)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for HighTower Advisors

Top funds holding Revolution Medicines

Vanguard Group
BlackRock
Farallon Capital Management
Wellington Management Company
Henderson Group
Baker Bros. Advisors
FMR
Nextech Invest
T. Rowe Price Associates
State Street Corporation
Paradigm Biocapital Advisors
Bellevue Group
Boxer Capital Management
BVF
Alphabet

View all funds holding Revolution Medicines